Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Promino Nutritional Sciences Inc C.MUSL

Alternate Symbol(s):  MUSLF

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical company. The Company is specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. The Company's lead product, Rejuvenate, is a formulation that is clinically proven to assist in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Rejuvenate helps boost energy and strengthen the metabolism and immune system. The Company also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury.


CSE:MUSL - Post by User

Post by waves1on May 18, 2022 3:06pm
62 Views
Post# 34693241

Q1 2022 sales almost surpassed entire 2021 year

Q1 2022 sales almost surpassed entire 2021 year Great discussion on Element Nutritional Sciences ($ELMT.c $ELNSF) recent growth and listings from CEO Stuart Lowther and Jay Martin:
https://www.youtube.com/watch?v=Gjta-EhHBUQ&ab_channel=TheJayMartinShow

$ELMT has been experiencing significant growth, with Q1 2022 sales hitting 2.1M & almost surpassing sales for the entire 2021 year which were 2.5m, a YoY quarter increase of 467% which can be attributed to reorders and landing big mass-market retailers.

Lowther highlights the significance of reorders as they show that products are moving off the shelf on a consistent daily basis, generating revenue for both $ELMT and the retailers which in turn makes it easier to get additional products on their shelves.

Going forward, $ELMT has a Rejuvenate muscle activator that has just been brought to pilot production and is expected to be on shelves by Q3 of this year, as well as a 3-year pipeline of products with 5 additional categories for Rejuvenate.

Given $ELMT is set to continue on it's current growth path and is on track to hit a target run rate of 10M, it's got tons of potential IMO
<< Previous
Bullboard Posts
Next >>